P53 MODULATES TRABECTEDIN MEDIATED CYTOTOXICITY IN GLIOBLASTOMA MULTIFORME CELLS (U-87MG AND T98G)

Basit Öğe Kaydı
dc.contributor.authorBozkurt, E.
dc.contributor.authorAtmaca, H.
dc.contributor.authorUzunoglu, S.
dc.contributor.authorUslu, R.
dc.contributor.authorKaraca, B.
dc.date.accessioned2019-10-27T21:41:40Z
dc.date.available2019-10-27T21:41:40Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description11th International Congress on Targeted Anticancer Therapies (TAT) -- MAR 04-06, 2013 -- Paris, FRANCEen_US
dc.description.sponsorshipNatl Canc Inst, Ctr Canc Res, Novartis Pharma, AbbVie, Astex Pharmaceut, Boehringer Ingelheim Int, Roche, Servier, Pfizer Pharma, Sanofi-Aventis Franceen_US
dc.identifier.endpage30en_US
dc.identifier.issn0923-7534
dc.identifier.startpage30en_US
dc.identifier.urihttps://hdl.handle.net/11454/46719
dc.identifier.volume24en_US
dc.identifier.wosWOS:000316125600084en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleP53 MODULATES TRABECTEDIN MEDIATED CYTOTOXICITY IN GLIOBLASTOMA MULTIFORME CELLS (U-87MG AND T98G)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu